Comparative immunological response of commercial oil based and liposomal vaccines of avian influenza H7

Pakistan Journal of Biological Sciences

Volumn 9, Issue 13, 2006, Pages 2402-2410

  Farooq, Khalid ^a   Hameed, Abdul ^a   Javed, Tariq ^a   Ullah, Ikram ^a   Khan, Abdul Wali ^a   Khan, Hassan ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Adjuvant; Avian influenza; Immunity; Liposomes; Oil base; Vaccines

Indexed keywords

AVES;

EID: 33845249129     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2006.2402.2410     Document Type: Article

References (50)

1. Alexander, D.J., 2000. A review of avian influenza. In Proceedings of the European Society for Veterinary Virology (ESVV) Symposium on influenza viruses of wild and domestic animals. Vet. Micro., 74: 3-13.
2. Alonso-Romanowski, S., N.S. Chiaramoni, V.S. Lioy, R.A. Gargini, L.I. Viera and M.C. Taira, 2003. Characterization of diacetylenic liposomes as carriers for oral vaccines. Chem. Phys. Lipids, 122: 191-203.
3. Anonymous, 2004. Transboundry Animal Diseases Bulletin. Emergency Prevention System (EMPRES) (25), Jan-June 2004.
4. Babai, I., S. Samira, Y. Barenholz, Z. Zakay-Rones and E. Kedar, 1999. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice. Vaccine, 17: 1223-1238.
5. Baldo, T., C. Menegon, A. Bonello, R. Floreani, Trivello and Mariutto Collaborative Group, 2001. Comparison of three different influenza vaccines in institutionalised elderly. Vaccine, 19: 3472-3475.
6. Bankowski, R.A., 1981. Introduction and Objectives of the Symposium. In: Proc. 1st International Symposium on Avian Influenza (April 22-24), Beltsville, M.D. and R.A. Bankowski (Eds.) 7-14. United States Animal Health Association, Richmond, VA. 7-14.
7. Ben, A.E.T.S., G. Gregoriadis, C.W. Potter and R. Jennings, 1993. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: Role in protection against influenza A in mice. Vaccine, 11:1302-1309.
8. Ben, A.E.T.S., C.W. Potter, G. Gregoriadis, C. Adithan and R. Jennings, 1994. IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines. J. Med. Microbiol., 40: 261-269.
9. Budai, M. and M. Szogyi, 2001. Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes. Acta. Pharm. Hung., 71: 114-118.
10. Conne P., P. Gauthey Vernet, B, Althaus, J.U. Que, B. Finkel, R. Gluck and S.J. Cryz Jr, 1997. Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients. Vaccine, 15: 1675-1679.
11. Coulter, A., T.Y. Wong, D. Drane, J. Bates, R. Macfarlan and J. Cox, 1998. Studies on experimental adjuvanted influenza vaccines: Comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines. Vaccine, 16: 1243-1253.
12. Deliyannis, G., D.C. Jackson, W. Dyer, J. Bates, A. Coulter, L. Harling-McNabb and L.E. Brown, 1998. Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use. Vaccine, 16: 2058-2068.
13. Easterday, B.C., V.S. Hinshaw and D.A. Halvorson, 1997. Influenza. In: Diseases of Poultry. Calnek, B.W., H.J. Barnes, C.W. Beard, L.R. McDougald and Y.M. Saif (Eds.) Iowa State University Press, Ames, IA., pp: 583-605.
14. European Commission, 2000. The Definition of Avian Influenza: The use of Vaccination against Avian Influenza. Scientific Committee on Animal Health and Animal Welfare, Health and Consumer Protection Directorate-General of the European Commission, 36.
15. FAO, 2002. Vaccines and Adjuvants for Veterinary Use. www.exopol.com http://www.fao.org/ag/againfo/subjects/en/health/diseasescards/avian recomm.html.
16. FAO, 2004. Technical Consultation on the Control of Avian Influenza. Animal Health Special Report.http://www.fao.org/ag/againfo/subjects/en/health/ disease scards/avian recomm.html.
17. Fatunmbi, O.O., J.A. Newman, V. Sivanandan and D.A. Halvorson, 1992. Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant. Vaccine, 10: 623-626.
18. Garcia, J. and P.M. Alvarez, 1999. La influenza aviar en Mexico. Memorias Simposio international Sobre Influenza Aviar. Sociedad Venezolana de Veterinrios Especialistas en Aves (SOVVEA), Maracay. Venezuela.
19. Garcia, M., J.M. Crawford, J.W. Latimer, E. RiveraCruz and M.L. Perdue, 1996. Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico. J. Gen. Virol., 77: 1493-1504.
20. Gasparini, R., T. Pozzi, E. Montomoli, E. Fragapane, F. Senatore, M. Minutello and A. Podda, 2001. Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. Eur. J. Epidemiol., 17: 135-140.
21. Gluck, R., 1999. Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs). Vaccine, 17: 1782-1787.
22. Halvorson, D.A., 1995. Avian influenza control in Minnesota. Poul. Digest., 54: 12-19.
23. Hehme, N., H. Engelmann, W. Kuenzel, E. Neumeier and R. Saenger, 2004. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. Virus. Res., 103: 163-171.
24. Hjorth, R.N., G.M. Bonde, E.D. Piner, K.M. Goldberg and M.H. Levner, 1997. The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse. Vaccine, 15: 541-546.
25. Huckriede, A., L. Bungener, T. Daemen and J. Wilschut, 2003. Influenza virosomes in vaccine development. Method. Enzymol., 373: 74-91.
26. Joseph, A.B., L.H. Igal, P.F. Alla, Z. Evelyne, Z.R. Zichria, R. Eyal, H. Tomoko, T. Kenji, B. Yechezkel and K. Eli, 2002. Liposomal immunostimulatory DNA sequence (ISS-ODN): An efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines. Vaccine, 20: 3342-3354.
27. Katz, J.M., X. Lu, C.W. Todd and M.J. Newman, 2000. A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice. Vaccine, 18: 2177-1287.
28. Kedar, E., Y. Rutkowski, E. Braun, N. Emanuel, Y. Barenholz, 1994. Delivery of cytokines by liposomes I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes J. Immunother. Emphasis. Tumor. Immunol., 16: 47-59.
29. Kraaijeveld, C.A., M. Schilham, J. Jansen, B. Benaissa-Trouw, M. Harmsen, H.A. Van and H. Snippe, 1984. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses. Clin. Exp. Immunol., 56: 509-514
30. Lachman, L.B., L.C. Shih, X.M. Rao, X. Hu, C.D. Bucana, S.E. Ullrich and J.L. Cleland, 1995. Cytokine-containing liposomes as adjuvants for HIV subunit vaccines. AIDS. Res. Hum. Retrovir., 11: 921-932.
31. Mbawuike, I.N., P.R. Wyde and P.M. Anderson, 1990. Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes. Vaccine, 8: 347-352.
32. Minutello, M., F. Senatore, G. Cecchinelli, M. Bianchi, T. Andreani, A. Podda and P. Crovari, 1999. Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine, 17: 99-104.
33. Naeem, K., 1998. The avian influenza outbreak in South Central Asia. In: Proceedings of the 4th International Symposium on Avian Influenza. 1997, pp: 31-35.
34. Nicholson, K.G., A.E. Colegate, A. Podda, I. Stephenson, J. Wood, E. Ypma and M.C. Zambon, 2001. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet, 357: 1937-1943.
35. OIE, 1996. Office International des Epizooties (OIE). Highly pathogenic avian influenza (fowl plaque). In: Manual of standards for diagnostic tests and vaccines, 3rd Edn., OIE, Paris, France. pp: 155-160.
36. Perdue, M., J. Crawford, M. Garcia, J. Latimer and D. Swayne, 1998. Occurrence and possible mechanisms of cleavage site insertions in the avian influenza hemagglutinin gene. In: Proceedings of the 4th International Symposium on Avian Influenza. Athens, GA, USA., pp: 182-193.
37. Podda, A., 2001. Vaccines with novel adjuvants: Experience with the MF59-adjuvanted vaccine. Vaccine, 19: 2673-2680.
38. Pomeroy, B.S., 1995. Report of subcommittee on avian influenza. Proceedings of the US Animal Health Associat., 99: 569-584.
39. Powers, D.C., M.C. Manning, P.J. Hanscome and P.J.F. Pietrobon, 1995. Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly. J. Infect. Dis., 172: 1103-1107.
40. Powers, D.C., 1997. Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults. Mech. Ageing Dev., 93: 179-188.
41. Stephenson, I., K.G. Nicholson, A. Colegate, A. Podda, J. Wood, E. Ypma and M. Zambon, 2002. Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population. Vaccine, 21: 1687-1693.
42. Stone, H.D., 1987. Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. Avi. Dis., 31: 483-490.
43. Stone, H.D., 1993. Efficacy of experimental animal and vegetable oil-emulsion vaccines for Newcastle disease and avian influenza. Avi. Dis., 37: 399-405.
44. Swayne, D.E. and D.L. Suarez, 2000. Highly Pathogenic Avian influenza. Revue Scientifique et Teechnique Office Intl. des Epozooties, 20: 463-482.
45. Swayne, D.E., 2003. Vaccines for List A poultry diseases: Emphasis on avian influenza. Dev. Biol. (Basel)., 114: 201-112.
46. Swayne, D.E., 2004. Avian Influenza, Vaccines and Control. Poul. Sci., 83: 79.
47. Verma, I., R. Pandey and G.K. Khuller, 2004. Liposomes as adjuvant for anti-mycobacterial vaccine development. Ind. J. Exp. Biol., 42: 949-954.
48. Voinea, M. and M. Simionescu, 2002. Designing of 'intelligent' liposomes for efficient delivery of drugs. J. Cell Mol. Med., 6: 465-474.
49. WHO., 1980. World Health Organization Expert Committee. A revision of the system of nomenclature for influenza viruses: A WHO Memorandum. Bull. WHO., 58: 585-591.
50. Yehuda, A., A. Joseph, E. Zeira, S. Even-Chen, I. Louria-Hayon, I. Babai, Z. Zakay-Rones, E. Greenbaum, Y. Barenholz and E. Kedar, 2003. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults. J. Med. Virol., 69: 560-567.